$Marked Improvement in Refractory TTP Directly after H. pylori Eradication Therapy$

Marked Improvement in Refractory TTP Directly after H. pylori Eradication Therapy

Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder involving thrombotic microangiopathy and is characterized by increased platelet aggregation throughout the body. Acquired TTP can be triggered by a variety of conditions including infections. We hereby describe a case report of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Irina Gringauz, Narin Nard Carmel-Neiderman, Tobin Mangel, Orith Portnoy, Gad Segal, Idan Goren
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Case Reports in Hematology
Online Access:	http://dx.doi.org/10.1155/2016/1568586
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Remission of Severe, Relapsed, and Refractory TTP after Multiple Cycles of Bortezomib
by: Manu R. Pandey, et al.
Published: (2017-01-01)

Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication
by: Wenming Wu, et al.
Published: (2012-01-01)

Hp and pH: Implications for the Eradication of Heliobacter pylori
by: Richard H Hunt
Published: (1993-01-01)

Risks and Benefits of Helicobacter pylori Eradication: Current Status
by: Richard H Hunt, et al.
Published: (2002-01-01)

Utility of Serology in Determining Helicobacter pylori Eradication after Therapy
by: Carlo A Fallone, et al.
Published: (1998-01-01)

Rational choice of eradication therapy of <i>Helicobacter pylori</i> infection
by: T. L. Lapina, et al.
Published: (2013-10-01)

Improvement of Helicobacter pylori eradication efficacy at stomach and duodenum peptic ulcers
by: Natalya O. Schanova, et al.
Published: (2016-08-01)

The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
by: A. A. Sheptulin
Published: (2018-08-01)

Helicobacter pylori Eradication in Non-Ulcer Dyspepsia: Clearing up the Controversy
by: Carlo A Fallone
Published: (2004-01-01)

Helicobacter pylori Recurrence after Eradication Therapy in Jiangjin District, Chongqing, China
by: Gang Zhou
Published: (2020-01-01)

Ripeness Levels and Their Relations with the Success of the Negotiation Method: CPP-NPA, TTP, IRA
by: Emrah KAYA
Published: (2023-06-01)

<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Role of Helicobacter pylori Eradication Therapy on Platelet Recovery in Chronic Immune Thrombocytopenic Purpura
by: Khan Sheema, et al.
Published: (2017-01-01)

First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin
by: Soichiro Sue, et al.
Published: (2017-01-01)

Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials
by: Bum Jun Kim, et al.
Published: (2018-01-01)

Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
by: Manning Li, et al.
Published: (2025-02-01)

Short-term endoscopic alterations of early gastric cancer after successful eradication of Helicobacter pylori
by: Xiaohan Yan, et al.
Published: (2025-02-01)

Is Helicobacter pylori eradication required for non-steroidal anti-inflammatory drug-associated erosions and ulcers?
by: A. Ye. Karateyev, et al.
Published: (2018-08-01)

What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing Research
by: Han-Yi Song, et al.
Published: (2018-01-01)

Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
by: Sung Min Jung, et al.
Published: (2016-01-01)

High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota
by: Jia-Lun Guan, et al.
Published: (2025-01-01)

Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy
by: Sotirios D. Georgopoulos, et al.
Published: (2012-01-01)

Comment #2 on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
by: Davide Giuseppe Ribaldone, et al.
Published: (2018-01-01)

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
by: Meng-Chieh Wu, et al.
Published: (2017-01-01)

Efficacy of a “Rescue” Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures
by: Maria Pina Dore, et al.
Published: (2012-01-01)

H. pylori-Associated Gastritis, Gastritis after H. pylori Eradication and H. pylori-Negative Gastritis: Algorithm of Diagnosis and Treatment (Literature Review and Resolution of the Expert Panel of the Russian Gastroenterological Association)
by: V. T. Ivashkin, et al.
Published: (2024-08-01)

ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers
by: Khalid Hamid Changal, et al.
Published: (2016-01-01)

Mitomycin-C-Induced TTP/HUS Treated Successfully with Rituximab: Case Report and Review of the Literature
by: Gunjan Shah, et al.
Published: (2013-01-01)

Results of long-term follow-up of patients with chronic gastritis after <i>H. pylori</i> eradication
by: T. L. Lapina, et al.
Published: (2015-09-01)

Modern Approaches to <i>H. pylori</i> Eradication Therapy in Adults (Literature Review and Resolution of Experts Council)
by: V. Т. Ivashkin, et al.
Published: (2023-05-01)

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
by: Sung-Shuo Kao, et al.
Published: (2012-01-01)

Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01)

Helicobacter pylori infection diagnostics and choice of eradication treatment: results of inquiry of doctors from different regions of Russian Federation
by: N. N. Dekhnich, et al.
Published: (2018-08-01)

Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status
by: Luca Formichella, et al.
Published: (2017-01-01)

Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status
by: Ju Seok Kim, et al.
Published: (2016-01-01)

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
by: Wei-Chen Tai, et al.
Published: (2013-01-01)

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
by: Ayotola Fatola, et al.
Published: (2025-01-01)

The Role of Lactobacillus reuteri DSMZ17648 for Helicobacter pylori eradication therapy (Review of literature and advisory council resolution, February 28, 2018)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Estimation of cytoprotective effect of bismuth tripotassium dicitrate on gastric mucosa at <i>H. pylori</i> eradication and long-term drug intake
by: A. V. Kononov, et al.
Published: (2014-12-01)

Weizmannia coagulans BC99 modulate gut microbiota after Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial
by: Ying Wu, et al.
Published: (2025-02-01)